The British College of Aesthetic Medicine has published its annual survey results for 2017-2018, covering botulinum toxin, dermal filler and laser treatments.
The pooled data was collected from 334 doctors and dentists, representing 95% of the current BCAM membership. According to BCAM, one of the most important functions of this annual review was to encourage aesthetic practitioners to document the services they provide in a structured way and for this to be available in anonymised collated form.
The study highlighted that botulinum toxin treatments were up 30% in comparison to the previous year, with only 5% of practitioners stating they experienced any form of adverse event from toxin treatments.
The figures also demonstrated that 40% of the dermal filler treatments that took place in 2017-2018 were for volumising purposes, and one third of treatments targeted facial wrinkles . When asked about adverse events following a dermal filler treatment, only 2.3% of practitioners reported experiencing an adverse event.
The results also revealed that only 37% of doctors and dentists provided light-based therapies in their practices, with 65% of these treatments targeting thread veins.
The data also demonstrated that only 5% of BCAM members have been practising aesthetic medicine for less than three years.
To read the full report, visit the BCAM website.